Real-World Results on Ibrutinib in Relapsed/Refractory CLL: A 21-Month Follow-up of 95 Swedish Patients Treated in a Compassionate Use Program

被引:0
|
作者
Winqvist, Maria
Andersson, Per-Ola
Asklid, Anna
Karlsson, Karin
Karlsson, Claes
Lauri, Birgitta
Lundin, Jeanette
Mattsson, Mattias
Norin, Stefan
Sandstedt, Anna Bergendahl
Hansson, Lotta
Osterborg, Anders
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5353
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Long-Term Follow-Up in Patients With Chronic Myeloid Leukemia Treated With Ponatinib in a Real-World Cohort: Safety and Efficacy Analysis
    Osorio, Maria Jose Mela
    Moiraghi, Beatriz
    Osycka, Maria Victoria
    Pavlovsky, Miguel A.
    Varela, Ana Ines
    Del Prete, Georgina Emilia Bendek
    Tosin, Maria Fernanda
    Perez, Mariel Ana
    Riva, Maria Elisa
    Berrios, Roxana Ramirez
    Fernandez, Isolda
    Massa, Federico Sackmann
    Giere, Isabel
    Sighel, Carolina
    Pavlovsky, Carolina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (03): : 158 - 164
  • [42] Real-World Study of Polatuzumab Vedotin-Based Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Chinese Cohort: Updated Results of 2-Year Follow-up
    Wu, Jianqiu
    Li, Fei
    Wuxiao, Zhi-Jun
    Tang, Weiyan
    Teng, Yue
    Liu, Yanyan
    Chu, Han
    Wu, Zhiya
    Shen, Yiwen
    Kong, Fancong
    Yao, Zhihua
    Zhou, Weilun
    Feng, Jifeng
    BLOOD, 2023, 142
  • [43] An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer
    Madhusudan Koya
    Sue Osborne
    Christophe Chemaslé
    Sima Porten
    Anne Schuckman
    Andrew Kennedy-Smith
    BMC Urology, 20
  • [44] An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer
    Koya, Madhusudan
    Osborne, Sue
    Chemasle, Christophe
    Porten, Sima
    Schuckman, Anne
    Kennedy-Smith, Andrew
    BMC UROLOGY, 2020, 20 (01)
  • [45] Longest available clinical follow-up of a cohort of "real-world" patients treated exclusively with drug-eluting stents: Results of 12 years of the DESIRE (Drug-Eluting Stents In the REal world) Registry
    Costa, Jose D., Jr.
    Sousa, Amanda
    Moreira, Adriana
    Costa, Ricardo A.
    Cano, Manuel N.
    Maldonado, Galo
    Neto, Cantidio Campos
    Damiani, Lucas P.
    Siqueira, Dimytri A.
    Eduardo Sousa, J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B169 - B169
  • [46] RESULTS OF 13 YEARS OF THE DESIRE (DRUG-ELUTING STENTS IN THE REAL WORLD) REGISTRY: THE LONGEST AVAILABLE CLINICAL FOLLOW-UP OF A COHORT OF "REAL-WORLD" PATIENTS TREATED EXCLUSIVELY WITH DRUG-ELUTING STENTS
    Costa, Jose de Ribamar
    Sousa, Amanda
    Moreira, Adriana
    Costa, Ricardo
    Cano, Manuel
    Maldonado, Galo
    Damiani, Lucas
    Eduardo Sousa, J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1700 - A1700
  • [47] Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials
    Martino, Enrica Antonia
    Palmieri, Salvatore
    Galli, Monica
    Derudas, Daniele
    Mina, Roberto
    Della Pepa, Roberta
    Zambello, Renato
    Vigna, Ernesto
    Bruzzese, Antonella
    Mangiacavalli, Silvia
    Zamagni, Elena
    Califano, Catello
    Musso, Maurizio
    Conticello, Concetta
    Cerchione, Claudio
    Mele, Giuseppe
    Di Renzo, Nicola
    Offidani, Massimo
    Tarantini, Giuseppe
    Casaluci, Gloria Margiotta
    Rago, Angela
    Ria, Roberto
    Uccello, Giuseppina
    Barila, Gregorio
    Palumbo, Gaetano
    Pettine, Loredana
    Vincelli, Iolanda Donatella
    Brunori, Marino
    Accardi, Fabrizio
    Amico, Valeria
    Amendola, Angela
    Fontana, Raffaele
    Bongarzoni, Velia
    Rossini, Bernardo
    Cotzia, Emilia
    Gozzetti, Alessandro
    Rizzi, Rita
    Sgherza, Nicola
    Reddiconto, Giovanni
    Maroccia, Antonio
    Franceschini, Luca
    Bertuglia, Giuseppe
    Nappi, Davide
    Barbieri, Emiliano
    Gamberi, Barbara
    Petrucci, Maria Teresa
    Di Raimondo, Francesco
    Neri, Antonino
    Morabito, Fortunato
    Musto, Pellegrino
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (04)
  • [48] Real-World Use of Tocilizumab in Rheumatoid Arthritis Patients: Cardiovascular Risk, Concomitant Treatment, and Outcomes over 6 Months of Follow-up
    Haraoui, Boulos
    Jamal, Shahin
    Ahluwalia, Vandana
    Manchanda, Tarang
    Khraishi, Majed M.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [49] Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings
    Blauvelt, Andrew
    Shi, Nianwen
    Murage, Mwangi J.
    Kern, Scott A.
    Somani, Najwa
    Burge, Russel
    Ridenour, Terri L.
    Lew, Carolyn R.
    Zimmerman, Nicole M.
    Zhu, Baojin
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 741 - 749
  • [50] Long-Term Follow-Up of Elderly Patients with Acute Myeloid Leukemia Treated with Decitabine: A Real-World Study of the Apulian Hematological Network
    Dargenio, Michelina
    Tarantini, Giuseppe
    Cascavilla, Nicola
    Pavone, Enzo
    Musto, Pellegrino
    Mazza, Patrizio
    Melillo, Lorella
    Pastore, Domenico
    Guarini, Attilio
    Buquicchio, Caterina
    Fina, Maria Paola
    Federico, Vincenzo
    Santeramo, Teresa Maria
    Urbano, Marina Aurora
    Leo, Mariangela
    Carluccio, Vera
    Carluccio, Paola
    Delia, Mario
    Carlino, Daniela
    Vergine, Carolina
    Gagliardi, Vito Pier
    Greco, Giuseppina
    Sibilla, Silvia
    Abbenante, Mariachiara
    Rossi, Giovanni
    Spinosa, Giuseppina
    Mazzone, Annamaria
    Aprile, Lara
    de Fazio, Vincenza
    Pasciolla, Crescenza
    Specchia, Giorgina
    Di Renzo, Nicola
    CANCERS, 2022, 14 (03)